Dr. Aamr Arif Herekar, MD

Dr. Herekar practices at Advanced Neurology Epilepsy And Sleep Center in El Paso, Texas.

Dr. Herekar's NPI, 1376741330, was assigned on July 10, 2007. Dr. Herekar graduated from Dow University of Health Sciences in 2005. Dr. Herekar holds Texas license Q7055.

Dr. Herekar's primary practice is Advanced Neurology Epilepsy and Sleep Center, at 7100 Westwind Dr Suite 300 Suite 300, El Paso, TX 79912-1743. The practice phone is (915) 974-2200.

Dr. Herekar's primary practice is Advanced Neurology Epilepsy And Sleep Center in El Paso, Texas. Dr. Herekar is also affiliated with University Medical Center of El Paso. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Dr. Herekar to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Herekar practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Herekar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Herekar is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Herekar's licenses on file in 6 states: Texas, New Mexico, Colorado, Florida, Kansas and Ohio.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury and hypersomnia among the conditions Dr. Herekar treats.

CMS data shows 3,199 Medicare services from Dr. Herekar across 21 procedure codes in 2024, for 612 Medicare patients. Medicare paid $299,976 for them. Every service was in an office.

CMS counts 612 Medicare patients who saw Dr. Herekar in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Herekar's median patient age at 61, with 57% women.

In 2024, Dr. Herekar wrote 2,166 Medicare Part D claims for 579 patients. 86% of them were for generic drugs. CMS names the drug for 1,833 of them, across 42 drugs with 11 or more claims each, at $394,112 in total drug cost. In 2023, CMS named 807 claims across 28 drugs.

Dr. Herekar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Herekar as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Herekar to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Sleep Apnea, Obstructive and Status Epilepticus. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Herekar that name 2 trials.

CMS Open Payments shows 1,016 general payments to Dr. Herekar from 69 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. SK Life Science, Inc. paid the most, $18,825. It also lists 15 research payments totaling $30,273 from 2022 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Herekar, most recently CMS Stage 1 EHR in 2013.

Dr. Herekar graduated from Dow University of Health Sciences in 2005.

Dr. Herekar is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.